Who’s Hired? Neuraxpharm, Lupin And ANI Announce Appointments
As Medicines For Europe And Australia’s GBMA Add Board Members
Neuraxpharm, Lupin and ANI have announced changes within their leadership teams, while board members have joined industry associations Medicines for Europe and Australia’s GBMA.
You may also be interested in...
Neuraxpharm Expands European Reach With Dutch Operation
Neuraxpharm has made its latest move into a new European market, this time opening up a new unit in the Netherlands that will be led by the firm’s German head Philipp Pohoralek as country manager.
Lupin Builds On Chinese Ambitions With Yabao Alliance
Lupin has built on a recent alliance in China with Foncoo by agreeing a further partnership for the Chinese market, this time with Yabao Pharmaceutical.
ANI Expects Growth From Launches And Novitium Integration
ANI Pharma has outlined key pillars of its strategy to drive growth in the coming quarters as the company reported a slight increase in revenues in the fourth quarter of 2021. The company’s recent purified Cortrophin Gel launch is off to a good start, as ANI leadership counts on its commercial longevity.